Idexx Laboratories Inc (IDXX) fundamentals from SEC filings — revenue $4.3B, net margin 24.6%, diluted EPS $13.08 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $3.4B | $3.7B | $3.9B | $4.3B |
| Net income | $744.8M | $679.1M | $845.0M | $887.9M | $1.1B |
| Net margin | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% |
| Diluted EPS | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 |
| Free cash flow | $636.0M | $394.1M | $772.9M | $808.1M | $1.1B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home